Largest Adcock Stakeholder To Decide Soon On $1.3 Billion CFR Offer
This article was originally published in PharmAsia News
Executive Summary
A key stakeholder in Adcock Ingram Holdings said it could have a decision as early as next week on whether to join the 45% of shareholders in favor of selling a controlling interest to China's CFR Pharmaceuticals.